Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations

Authors

DOI:

https://doi.org/10.14429/dlsj.9.19191

Keywords:

SARS-CoV-2, Vaccine, Pharmaceutical therapy, Challenges

Abstract

As new and changing SARS-CoV-2 variants are discovered, there is an increasing demand for more adaptable diagnostic tools capable of detecting SARS-CoV-2 infections. The wide range of symptoms experienced by infected individuals and unexpected variants make it more challenging than ever to create quick and accurate diagnostic tools. Pharmaceutical treatments and vaccinations are continually designed to strengthen the immune function and successfully combat SARS-CoV-2 and its variations. The discovery of new SARS-CoV-2 mutations and variants, along with the advancement of diagnostic methods that make it possible to identify them, have brought up a number of urgent issues that are covered in this review from a completely fresh perspective. Additionally, we go over the creation, composition, operating principles, benefits, and downsides of some of the most popular vaccinations and therapeutic medications, as well as the ensuing immunological influence.

Downloads

Published

2024-08-20

How to Cite

Kumari, D., Mavi, A. K., Chaudhary, J., Kumar, M., Gupta, R. K., & Kumar, U. (2024). Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations. Defence Life Science Journal, 9(3), 205–214. https://doi.org/10.14429/dlsj.9.19191

Issue

Section

Review Articles